Opthea Limited (OPT.AX)
AUD 0.66
(1.54%)
AUD 0.66
(1.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -220.24 Million USD | -3.95% |
| 2023 | -211.88 Million USD | -65.54% |
| 2022 | -127.99 Million USD | -110.55% |
| 2021 | -60.78 Million USD | -277.16% |
| 2020 | -16.11 Million AUD | 22.92% |
| 2019 | -20.91 Million AUD | -23.71% |
| 2018 | -16.9 Million AUD | -172.93% |
| 2017 | -6.19 Million AUD | 4.83% |
| 2016 | -6.5 Million AUD | -59.72% |
| 2015 | -4.07 Million AUD | -8.29% |
| 2014 | -3.76 Million AUD | 13.29% |
| 2013 | -4.33 Million AUD | 12.35% |
| 2012 | -4.95 Million AUD | 54.88% |
| 2011 | -10.97 Million AUD | -85.79% |
| 2010 | -5.9 Million AUD | 26.22% |
| 2009 | -8 Million AUD | -628.79% |
| 2008 | -1.09 Million AUD | -111.56% |
| 2007 | 9.5 Million AUD | 297.85% |
| 2006 | -4.8 Million AUD | -128.93% |
| 2005 | 16.59 Million AUD | 309.16% |
| 2004 | 4.05 Million AUD | 271.69% |
| 2003 | -2.36 Million AUD | 26.93% |
| 2002 | -3.23 Million AUD | -303.64% |
| 2001 | -801.17 Thousand AUD | -209.69% |
| 2000 | 730.41 Thousand AUD | -99.95% |
| 1999 | 1.58 Billion AUD | 128760.93% |
| 1998 | -1.22 Million AUD | -16.72% |
| 1997 | -1.05 Million AUD | -22.86% |
| 1996 | -857.58 Thousand AUD | -81.58% |
| 1995 | -472.28 Thousand AUD | -942.49% |
| 1994 | -45.3 Thousand AUD | 86.73% |
| 1993 | -341.34 Thousand AUD | -464.15% |
| 1992 | -60.5 Thousand AUD | 56.41% |
| 1991 | -138.8 Thousand AUD | 71.82% |
| 1990 | -492.57 Thousand AUD | -19.93% |
| 1989 | -410.72 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -147.41 Million USD | 0.0% |
| 2024 FY | -220.24 Million USD | -3.95% |
| 2023 FY | -211.88 Million USD | -65.54% |
| 2023 Q2 | -115.1 Million USD | 0.0% |
| 2023 Q4 | -96.84 Million USD | 0.0% |
| 2022 Q2 | -51.55 Million USD | 0.0% |
| 2022 Q4 | -79.81 Million USD | 0.0% |
| 2022 FY | -127.99 Million USD | -110.55% |
| 2021 FY | -60.78 Million USD | -277.16% |
| 2021 Q2 | -34.98 Million USD | 0.0% |
| 2020 Q4 | -8.49 Million AUD | 0.0% |
| 2020 FY | -16.11 Million AUD | 22.92% |
| 2020 Q2 | -7.62 Million AUD | 0.0% |
| 2019 Q2 | -11.28 Million AUD | 0.0% |
| 2019 Q4 | -9.62 Million AUD | 0.0% |
| 2019 FY | -20.91 Million AUD | -23.71% |
| 2018 Q4 | -5.47 Million AUD | 0.0% |
| 2018 FY | -16.9 Million AUD | -172.93% |
| 2017 FY | -6.19 Million AUD | 4.83% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 FY | -6.5 Million AUD | -59.72% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | -4.07 Million AUD | -8.29% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | -3.76 Million AUD | 13.29% |
| 2013 Q1 | -1.22 Million AUD | 0.0% |
| 2013 Q3 | -1.25 Million AUD | 0.0% |
| 2013 Q2 | -1.25 Million AUD | -2.0% |
| 2013 FY | -4.33 Million AUD | 12.35% |
| 2013 Q4 | - AUD | 100.0% |
| 2012 Q2 | -1.22 Million AUD | 52.2% |
| 2012 FY | -4.95 Million AUD | 54.88% |
| 2012 Q1 | -2.56 Million AUD | 0.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 Q3 | -1.22 Million AUD | 0.0% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 FY | -10.97 Million AUD | -85.79% |
| 2011 Q3 | -2.56 Million AUD | 0.0% |
| 2011 Q2 | -2.56 Million AUD | -47.74% |
| 2011 Q1 | -1.73 Million AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -1.73 Million AUD | 0.0% |
| 2010 Q1 | -2.48 Million AUD | 0.0% |
| 2010 Q2 | -1.73 Million AUD | 29.97% |
| 2010 FY | -5.9 Million AUD | 26.22% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 FY | -8 Million AUD | -628.79% |
| 2009 Q3 | -2.48 Million AUD | 0.0% |
| 2009 Q2 | -2.48 Million AUD | -334.0% |
| 2009 Q1 | -571.52 Thousand AUD | 0.0% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q3 | -571.52 Thousand AUD | 0.0% |
| 2008 Q2 | -571.52 Thousand AUD | -136.31% |
| 2008 Q1 | 1.57 Million AUD | 0.0% |
| 2008 FY | -1.09 Million AUD | -111.56% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 FY | 9.5 Million AUD | 297.85% |
| 2007 Q1 | -1.62 Million AUD | 0.0% |
| 2007 Q2 | 1.57 Million AUD | 196.63% |
| 2007 Q3 | 1.57 Million AUD | 0.0% |
| 2006 Q3 | -1.62 Million AUD | 0.0% |
| 2006 FY | -4.8 Million AUD | -128.93% |
| 2006 Q1 | - AUD | 0.0% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q2 | -1.62 Million AUD | 0.0% |
| 2005 FY | 16.59 Million AUD | 309.16% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 FY | 4.05 Million AUD | 271.69% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 Q2 | - AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 Q2 | - AUD | 0.0% |
| 2003 Q3 | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | -2.36 Million AUD | 26.93% |
| 2003 Q1 | - AUD | 0.0% |
| 2002 Q2 | - AUD | 0.0% |
| 2002 Q4 | - AUD | 0.0% |
| 2002 Q3 | - AUD | 0.0% |
| 2002 FY | -3.23 Million AUD | -303.64% |
| 2002 Q1 | - AUD | 0.0% |
| 2001 FY | -801.17 Thousand AUD | -209.69% |
| 2001 Q2 | - AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 Q3 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 FY | 730.41 Thousand AUD | -99.95% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 FY | 1.58 Billion AUD | 128760.93% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1998 Q1 | - AUD | 0.0% |
| 1998 Q2 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 FY | -1.22 Million AUD | -16.72% |
| 1997 FY | -1.05 Million AUD | -22.86% |
| 1997 Q4 | - AUD | 0.0% |
| 1997 Q2 | - AUD | 0.0% |
| 1997 Q3 | - AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1996 Q2 | - AUD | 0.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 FY | -857.58 Thousand AUD | -81.58% |
| 1996 Q1 | - AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1995 FY | -472.28 Thousand AUD | -942.49% |
| 1995 Q3 | - AUD | 0.0% |
| 1995 Q4 | - AUD | 0.0% |
| 1995 Q2 | - AUD | 0.0% |
| 1995 Q1 | - AUD | 0.0% |
| 1994 Q2 | - AUD | 0.0% |
| 1994 FY | -45.3 Thousand AUD | 86.73% |
| 1994 Q1 | - AUD | 0.0% |
| 1994 Q3 | - AUD | 0.0% |
| 1994 Q4 | - AUD | 0.0% |
| 1993 Q2 | - AUD | 0.0% |
| 1993 Q1 | - AUD | 0.0% |
| 1993 FY | -341.34 Thousand AUD | -464.15% |
| 1993 Q4 | - AUD | 0.0% |
| 1993 Q3 | - AUD | 0.0% |
| 1992 Q2 | - AUD | 0.0% |
| 1992 Q4 | - AUD | 0.0% |
| 1992 FY | -60.5 Thousand AUD | 56.41% |
| 1992 Q1 | - AUD | 0.0% |
| 1992 Q3 | - AUD | 0.0% |
| 1991 Q3 | - AUD | 0.0% |
| 1991 FY | -138.8 Thousand AUD | 71.82% |
| 1991 Q1 | - AUD | 0.0% |
| 1991 Q2 | - AUD | 0.0% |
| 1991 Q4 | - AUD | 0.0% |
| 1990 FY | -492.57 Thousand AUD | -19.93% |
| 1990 Q1 | - AUD | 0.0% |
| 1990 Q3 | - AUD | 0.0% |
| 1990 Q2 | - AUD | 0.0% |
| 1990 Q4 | - AUD | 0.0% |
| 1989 Q4 | - AUD | 0.0% |
| 1989 FY | -410.72 Thousand AUD | 0.0% |
| 1989 Q2 | - AUD | 0.0% |
| 1989 Q3 | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 3262.359% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -15076.112% |
| Zelira Therapeutics Limited | -36.56 Million AUD | -502.266% |
| Biome Australia Limited | -1.67 Million AUD | -13086.555% |
| Patrys Limited | -3.53 Million AUD | -6123.023% |
| Orthocell Limited | -7.18 Million AUD | -2967.029% |
| Imugene Limited | -149.68 Million AUD | -47.141% |
| Noxopharm Limited | -3.57 Million AUD | -6055.252% |
| PYC Therapeutics Limited | -37.72 Million AUD | -483.803% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | -1657.739% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -2573.474% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -3354.118% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -2160.12% |
| CSL Limited | 2.64 Billion AUD | 108.336% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -2418.194% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -9041.791% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 718.026% |
| Starpharma Holdings Limited | -8.16 Million AUD | -2597.393% |
| Nanollose Limited | -1.15 Million AUD | -18942.976% |
| Memphasys Limited | -4.44 Million AUD | -4858.151% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -13314.6% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 68031.928% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -4790.516% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | -1487.936% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -7589.164% |
| Race Oncology Limited | -13.81 Million AUD | -1493.724% |
| Nyrada Inc. | -1.38 Million AUD | -15787.882% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 4326.484% |
| Dimerix Limited | -17.07 Million AUD | -1189.845% |
| PharmAust Limited | -9.03 Million AUD | -2338.368% |
| Immutep Limited | -39.89 Million AUD | -452.036% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | -420.366% |
| Alterity Therapeutics Limited | -19.12 Million AUD | -1051.685% |
| BTC Health Limited | 1.05 Million AUD | 20970.351% |
| Acrux Limited | -5.8 Million AUD | -3697.278% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 240.209% |
| Biotron Limited | -3.43 Million AUD | -6308.863% |
| Tissue Repair Ltd | -4.13 Million AUD | -5222.295% |
| AdAlta Limited | -5.38 Million AUD | -3992.754% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | -359.325% |
| Hexima Limited | -933.87 Thousand AUD | -23483.732% |
| AnteoTech Limited | -8.88 Million AUD | -2380.059% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | -275.499% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | -1147.003% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -6308.794% |
| Actinogen Medical Limited | -13.04 Million AUD | -1588.419% |
| Immuron Limited | -6.93 Million AUD | -3074.909% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -3919.392% |